[HTML][HTML] Neuropathobiology of COVID-19: the role for glia

ME Tremblay, C Madore, M Bordeleau…�- Frontiers in cellular�…, 2020 - frontiersin.org
SARS-CoV-2, which causes the Coronavirus Disease 2019 (COVID-19) pandemic, has a
brain neurotropism through binding to the receptor angiotensin-converting enzyme 2�…

[HTML][HTML] A contemporary review on pathogenesis and immunity of COVID-19 infection

R Mirzaei, S Karampoor, M Sholeh, P Moradi…�- Molecular biology�…, 2020 - Springer
Emerging of the COVID-19 pandemic has raised interests in the field of biology and
pathogenesis of coronaviruses; including interactions between host immune reactions�…

[HTML][HTML] Retinal involvement and ocular findings in COVID-19 pneumonia patients

MP Pirraglia, G Ceccarelli, A Cerini, G Visioli…�- Scientific Reports, 2020 - nature.com
Abstract Changes in immune and coagulation systems and possible viral spread through the
blood–brain barrier have been described in SARS-CoV-2 infection. In this study, we�…

[HTML][HTML] COVID-19 and systemic lupus erythematosus: a case series

Y Gartshteyn, AD Askanase, NM Schmidt…�- The Lancet�…, 2020 - ncbi.nlm.nih.gov
The COVID-19 pandemic has spread across New York City, NY, USA, affecting more than
150 000 of its 8� 5 million inhabitants as of April 26, 2020. 1 Severe illness resulting in�…

[HTML][HTML] Association between autoimmune diseases and COVID-19 as assessed in both a test-negative case–control and population case–control design

R Murtas, A Andreano, F Gervasi, D Guido…�- Autoimmunity�…, 2020 - Springer
Background COVID-19 epidemic has paralleled with the so called infodemic, where
countless pieces of information have been disseminated on putative risk factors for COVID�…

[HTML][HTML] An open question: is it rational to inhibit the mTor-dependent pathway as COVID-19 therapy?

G Terrazzano, V Rubino, AT Palatucci…�- Frontiers in�…, 2020 - frontiersin.org
In December 2019, a novel coronavirus infection appeared in China (Wuhan City and Hubei
Province), causing the first cases of abnormal severe pneumonia. Since then, the SARS�…

[HTML][HTML] Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review

I Coskun Benlidayi, B Kurtaran, E Tirasci…�- Rheumatology�…, 2020 - Springer
Severe acute respiratory syndrome coranovirus-2 (SARS-CoV-2) infection has become an
important health-care issue worldwide. The coronavirus disease 2019 (COVID-19) has also�…

Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn

M Shahgolzari, A Yavari, Y Arjeini, SM Miri, A Darabi…�- Gene reports, 2021 - Elsevier
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) directly interacts
with host's epithelial and immune cells, leading to inflammatory response induction, which is�…

Update on antimalarials and systemic lupus erythematosus

G Ruiz-Irastorza, D Martin-Iglesias…�- Current Opinion in�…, 2020 - journals.lww.com
Recent evidence reinforces the central role of HCQ in SLE therapy. The reduction in activity,
damage accrual and mortality is consistent across studies, countries and ethnical groups�…

[HTML][HTML] The impact of telemedicine on rheumatology care

W Tang, S Inzerillo, J Weiner, L Khalili…�- Frontiers in�…, 2022 - frontiersin.org
Background The pandemic disrupted the care of patients with rheumatic diseases;
difficulties in access to care and its psychological impact affected quality of life�…